01-04-2022 | AA Amyloidosis | Correction
Correction to: Efficacy of canakinumab on AA amyloidosis in late-onset NLRP3-associated autoinflammatory disease with an I574F somatic mosaic mutation
Published in: Clinical Rheumatology | Issue 7/2022
Login to get access